Business NewsPR NewsWire • BioConnection to manufacture clinical trial material for Nykode Therapeutics' vaccine

BioConnection to manufacture clinical trial material for Nykode Therapeutics' vaccine

BioConnection to manufacture clinical trial material for Nykode Therapeutics' vaccine

OSS, Netherlands, Nov. 29, 2021 /PRNewswire/ -- BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that Nykode...

View More : https://www.prnewswire.com:443/news-releases/bioconnection-to-manufacture-clinical-trial-material-for-nykode-therapeutic...
Releted News by prnewswire
USD 361.56 million growth for GPU Database Market from 2020 to 2025 |Evolving Opportunities with BlazingSQL Inc., Brytlyt Ltd. & Hetero DB Co. Ltd.|17000+ Technavio Reports
Alfa Laval wins wastewater treatment order in Canada
Automotive Winches System (AWS) Market to Record 8.49% CAGR by 2025 | Bosch Rexroth AG and Ironman 4X4 Pty Ltd. Among Key Vendors | Technavio
BioConnection to manufacture clinical trial material for Nykode Therapeutics' vaccine
Modulaire Group releases third quarter 2021 Financial Report
MPC Energy Solutions publishes Q3 2021 results